A meta-analysis of clinical studies conducted during the West Africa Ebola virus disease outbreak confirms the need for randomized control groups
Dodd LE., Follmann D., Proschan M., Wang J., Malvy D., van Griensven J., Ciglenecki I., Horby PW., Ansumana R., Jiang J-F., Davey RT., Lane HC., Gouel-Cheron A.
Randomized controlled clinical trials are critical for evaluating new experimental therapeutics to treat Ebola virus disease.